Darci Joelle Phillips, MD
Dermatology · San Carlos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Phillips’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A137652 · Current
Licensed to practise in California · since 2015 · expires 2027-05-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$193,593
Medicare paid this office $193,593 for 822 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Destruction of skin growth, 1-14 growths | 354 | $45,103 | $108 |
| Return visit (30+ min) | 259 | $34,568 | $104 |
| Short return visit (20+ min) | 375 | $34,328 | $74 |
| New patient visit (30+ min) | 181 | $16,403 | $91 |
| Destruction of precancer skin growth, 1 growth | 237 | $12,802 | $47 |
See all 15 services
| Destruction of skin growth, 1-14 growths | 354 | $45,103 | $108 |
| Return visit (30+ min) | 259 | $34,568 | $104 |
| Short return visit (20+ min) | 375 | $34,328 | $74 |
| New patient visit (30+ min) | 181 | $16,403 | $91 |
| Destruction of precancer skin growth, 1 growth | 237 | $12,802 | $47 |
| New patient visit (45+ min) | 95 | $12,217 | $129 |
| Biopsy of related skin growth, first growth | 88 | $7,368 | $82 |
| Application of ultraviolet light to skin | 12 | $7,280 | $27 |
| Destruction of precancer skin growth, 2-14 growths | 167 | $6,058 | $7 |
| Destruction of precancer skin growth, 15 or more growths | 17 | $4,296 | $172 |
| Application of light to destroy precancer skin growth | 17 | $3,160 | $144 |
| Destruction of skin growth, 15 or more growths | 12 | $2,118 | $125 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 12 | $2,091 | $174 |
| Injection into skin growth, 1-7 growths | 23 | $1,222 | $51 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $21 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 1097 | More than 94% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 134 | More than 79% of doctors who do this |
Who their Medicare patients are
822 Original Medicare patients in 2024. Average age 75 · Under 65 2% · 85 and older 13% · Women 59% · Also on Medicaid 5% · Health risk score 0.79. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 55% · Coronary heart disease 20% · Diabetes 15% · Chronic kidney disease 13% · Cancer 13% · Atrial fibrillation 12% · Depression 10% · Heart failure 6% · COPD 6% · Stroke 4% · Dementia 3%.
The office billed $693,067, Medicare allowed $274,214 and paid $193,593; for 3,165 services of 33 kinds; $21 of it was for drugs given in the office and $193,572 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 822 | 3,165 | 75 | 0.79 | $693,067 | $193,593 |
| 2023 | 624 | 2,535 | 75 | 0.84 | $559,396 | $166,550 |
| 2022 | 490 | 1,889 | 75 | 0.81 | $389,798 | $120,775 |
| 2021 | 347 | 1,180 | 75 | 0.75 | $251,626 | $78,573 |
| 2020 | 154 | 536 | 74 | 0.90 | $111,896 | $28,093 |
| 2019 | 74 | 160 | 71 | 1.10 | $43,771 | $5,688 |
| 2018 | 11 | 20 | 66 | 1.09 | $4,989 | $1,041 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Destruction of skin growth, 1-14 growths | 280 | $37,475 | $112 |
| Short return visit (20+ min) | 355 | $34,334 | $75 |
| Return visit (30+ min) | 162 | $23,592 | $113 |
| New patient visit (30+ min) | 139 | $12,383 | $89 |
| Destruction of precancer skin growth, 1 growth | 185 | $10,385 | $47 |
| New patient visit (45+ min) | 71 | $9,567 | $135 |
| Biopsy of related skin growth, first growth | 106 | $9,472 | $84 |
| Destruction of precancer skin growth, 2-14 growths | 142 | $5,055 | $7 |
| Destruction of precancer skin growth, 15 or more growths | 15 | $4,008 | $174 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 11 | $3,114 | $283 |
| Destruction of skin growth, 15 or more growths | 15 | $2,201 | $129 |
| Punch biopsy, first skin growth | 13 | $1,694 | $130 |
| Injection into skin growth, 1-7 growths | 15 | $671 | $39 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $21 | None |
2022: 13 services
| Short return visit (20+ min) | 285 | $26,685 | $72 |
| Destruction of skin growth, 1-14 growths | 199 | $25,992 | $106 |
| New patient visit (30+ min) | 160 | $14,176 | $89 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 16 | $9,206 | None |
| Destruction of precancer skin growth, 1 growth | 161 | $8,839 | $48 |
| Biopsy of related skin growth, first growth | 81 | $7,339 | $84 |
| Return visit (30+ min) | 59 | $6,598 | $105 |
| Destruction of precancer skin growth, 2-14 growths | 113 | $3,798 | $7 |
| Application of light to destroy precancer skin growth | 17 | $3,323 | $151 |
| New patient visit (45+ min) | 23 | $3,101 | $135 |
| Injection into skin growth, 1-7 growths | 12 | $614 | $47 |
| Short return visit | 11 | $545 | $50 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $14 | None |
2021: 11 services
| Destruction of skin growth, 1-14 growths | 127 | $17,415 | $111 |
| Short return visit (20+ min) | 173 | $17,143 | $78 |
| New patient visit (30+ min) | 127 | $10,535 | $83 |
| New patient visit (45+ min) | 49 | $6,476 | $132 |
| Return visit (30+ min) | 43 | $5,669 | $107 |
| Destruction of precancer skin growth, 1 growth | 90 | $5,384 | $49 |
| Biopsy of related skin growth, first growth | 44 | $4,210 | $94 |
| Destruction of precancer skin growth, 2-14 growths | 59 | $2,161 | $7 |
| Injection into skin growth, 1-7 growths | 13 | $826 | $46 |
| Short return visit | 11 | $509 | $46 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $20 | None |
2020: 8 services
| New patient visit (30+ min) | 47 | $4,421 | $94 |
| Destruction of skin growth, 1-14 growths | 31 | $3,792 | $112 |
| Biopsy of related skin growth, first growth | 39 | $3,691 | $95 |
| Short return visit (20+ min) | 40 | $3,365 | $72 |
| Return visit (30+ min) | 29 | $2,629 | $91 |
| Destruction of precancer skin growth, 1 growth | 37 | $1,746 | $46 |
| New patient visit (15+ min) | 25 | $1,437 | $57 |
| Destruction of precancer skin growth, 2-14 growths | 29 | $1,024 | $6 |
2019: 6 services
| Return visit (30+ min) | 24 | $1,523 | $61 |
| New patient visit (30+ min) | 23 | $1,249 | $54 |
| Short return visit (20+ min) | 22 | $1,007 | $42 |
| Destruction of precancer skin growth, 1 growth | 17 | $609 | $36 |
| Destruction of skin growth, 1-14 growths | 12 | $571 | $48 |
| Destruction of precancer skin growth, 2-14 growths | 11 | $69 | $2 |
Medicaid work
$1,238 in 2023
Medicaid paid $1,238 for 28 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 28 | $1,238 |
| 2023 | 28 | 1 | 13 | $1,238 |
| 2020 | 74 | 2 | 26 | $328 |
| 2019 | 124 | 4 | 21 | $365 |
See the largest Medicaid services in earlier years
2020
| Return visit (30+ min) | 42 | $219 |
| Short return visit (20+ min) | 32 | $109 |
2019
| Return visit (30+ min) | 47 | $166 |
| New patient visit (30+ min) | 13 | $127 |
| Short return visit (20+ min) | 52 | $41 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 12 | $30 |
Drugs they prescribed that Part D paid
$305,669
Pharmacies billed $305,669 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,135) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
1,083 generic and 52 brand-name prescriptions · $305,669 in drug cost · 54 antibiotic prescriptions to 41 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Otezla | 13 | $64,306 | $4,947 |
| Fluocinonide | 129 | $5,586 | $43 |
| Metronidazole | 36 | $2,445 | $68 |
| Triamcinolone Acetonide | 172 | $2,106 | $12 |
| Clobetasol Propionate | 43 | $1,860 | $43 |
See all 23 drugs
| Otezla | 13 | $64,306 | $4,947 |
| Fluocinonide | 129 | $5,586 | $43 |
| Metronidazole | 36 | $2,445 | $68 |
| Triamcinolone Acetonide | 172 | $2,106 | $12 |
| Clobetasol Propionate | 43 | $1,860 | $43 |
| Ciclopirox | 102 | $1,692 | $17 |
| Tretinoin | 40 | $1,691 | $42 |
| Clindamycin Phosphate | 36 | $1,164 | $32 |
| Ciclopirox | 36 | $972 | $27 |
| Fluocinolone Acetonide | 16 | $917 | $57 |
| Nystatin | 60 | $889 | $15 |
| Mupirocin | 92 | $635 | $7 |
| Clotrimazole-Betamethasone | 39 | $581 | $15 |
| Minoxidil | 35 | $536 | $15 |
| Doxycycline Hyclate | 30 | $534 | $18 |
| Ketoconazole | 27 | $485 | $18 |
| Hydroxyzine | 16 | $462 | $29 |
| Mometasone Furoate | 17 | $270 | $16 |
| Cephalexin | 19 | $197 | $10 |
| Valacyclovir | 17 | $184 | $11 |
| Fluconazole | 19 | $177 | $9 |
| Hydrocortisone | 17 | $111 | $7 |
| Prednisone | 11 | $46 | $4 |
Year by year
| 2024 | 1,135 | 422 | 0% (0) | 5% | $305,669 |
| 2023 | 744 | 285 | 0% (0) | 6% | $228,645 |
| 2022 | 487 | 200 | 0% (0) | 6% | $143,350 |
| 2021 | 342 | 163 | 0% (0) | 4% | $15,759 |
| 2020 | 303 | 121 | 0% (0) | 9% | $28,685 |
| 2019 | 292 | 130 | 0% (0) | 13% | $22,803 |
| 2018 | 67 | 37 | 0% (0) | None | $4,432 |
| 2017 | 74 | 38 | 0% (0) | None | $3,474 |
| 2015 | 33 | 12 | None | None | $1,293 |
| 2014 | 70 | 18 | None | 24% | $6,991 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Fluocinonide | 54 | $2,691 | $50 |
| Ciclopirox | 70 | $2,276 | $33 |
| Clobetasol Propionate | 35 | $2,066 | $59 |
| Metronidazole | 27 | $1,774 | $66 |
| Doxycycline Hyclate | 32 | $1,668 | $52 |
| Triamcinolone Acetonide | 118 | $1,598 | $14 |
| Ciclopirox | 31 | $1,307 | $42 |
| Mupirocin | 69 | $869 | $13 |
| Clotrimazole-Betamethasone | 20 | $691 | $35 |
| Clindamycin Phosphate | 17 | $680 | $40 |
| Nystatin | 33 | $580 | $18 |
| Ketoconazole | 20 | $486 | $24 |
| Valacyclovir | 25 | $439 | $18 |
| Tretinoin | 13 | $405 | $31 |
| Fluconazole | 14 | $298 | $21 |
| Mometasone Furoate | 17 | $288 | $17 |
| Doxycycline Monohydrate | 11 | $193 | $18 |
| Cephalexin | 16 | $148 | $9 |
| Hydrocortisone | 15 | $68 | $5 |
2022: 13 drugs
| Otezla | 12 | $52,139 | $4,345 |
| Fluocinonide | 75 | $4,289 | $57 |
| Clobetasol Propionate | 39 | $3,985 | $102 |
| Ciclopirox | 36 | $1,133 | $31 |
| Doxycycline Hyclate | 17 | $1,024 | $60 |
| Triamcinolone Acetonide | 62 | $1,000 | $16 |
| Doxycycline Monohydrate | 22 | $792 | $36 |
| Ketoconazole | 26 | $603 | $23 |
| Ciclopirox | 12 | $541 | $45 |
| Nystatin | 25 | $441 | $18 |
| Mupirocin | 30 | $427 | $14 |
| Clotrimazole-Betamethasone | 14 | $311 | $22 |
| Hydrocortisone | 12 | $150 | $12 |
2021: 9 drugs
| Fluocinonide | 51 | $2,611 | $51 |
| Ciclopirox | 22 | $1,165 | $53 |
| Ketoconazole | 31 | $914 | $29 |
| Doxycycline Monohydrate | 17 | $837 | $49 |
| Triamcinolone Acetonide | 57 | $763 | $13 |
| Metronidazole | 12 | $682 | $57 |
| Mupirocin | 36 | $431 | $12 |
| Nystatin | 15 | $274 | $18 |
| Hydrocortisone | 16 | $142 | $9 |
2020: 6 drugs
| Fluocinonide | 63 | $4,728 | $75 |
| Clobetasol Propionate | 15 | $1,228 | $82 |
| Triamcinolone Acetonide | 54 | $872 | $16 |
| Ketoconazole | 33 | $601 | $18 |
| Mupirocin | 16 | $179 | $11 |
| Hydrocortisone | 18 | $150 | $8 |
2019: 9 drugs
| Clobetasol Propionate | 11 | $2,888 | $263 |
| Fluocinonide | 41 | $2,834 | $69 |
| Alclometasone Dipropionate | 14 | $1,164 | $83 |
| Triamcinolone Acetonide | 57 | $1,035 | $18 |
| Ketoconazole | 33 | $883 | $27 |
| Betamethasone Diprop Augmented | 11 | $850 | $77 |
| Mometasone Furoate | 15 | $504 | $34 |
| Hydrocortisone | 11 | $223 | $20 |
| Mupirocin | 12 | $181 | $15 |
2018: 3 drugs
| Fluocinonide | 16 | $1,051 | $66 |
| Ketoconazole | 12 | $599 | $50 |
| Triamcinolone Acetonide | 16 | $501 | $31 |
2017: 2 drugs
| Fluocinonide | 16 | $1,090 | $68 |
| Triamcinolone Acetonide | 20 | $444 | $22 |
Money from drug and device companies
$2,882 in 2025
| 2025 | 17 | 123 | None | $2,882 |
| 2024 | 12 | 53 | None | $1,336 |
| 2023 | 11 | 38 | None | $987 |
| 2022 | 7 | 15 | None | $352 |
| 2021 | 2 | 5 | None | $99 |
| 2020 | 1 | 3 | None | $69 |
| 2019 | 1 | 1 | None | $15 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Arcutis Biotherapeutics | Zoryve | $518 | 23 payments
|
| Janssen Biotech | Tremfya | $397 | 16 payments
|
| Lilly USA | Taltz | $357 | 16 payments
|
| Incyte | Opzelura | $309 | 13 payments
|
| Galderma Laboratories L.P. | Nemluvio | $233 | 8 payments
|
| Regeneron Healthcare Solutions | Dupixent | $176 | 7 payments
|
See all 123 published payments
| Janssen Biotech | Education · 2025-12-26 | Tremfya | $69 |
| Janssen Biotech | Meals · 2025-12-23 | Tremfya | $1 |
| Janssen Biotech | Meals · 2025-12-22 | Tremfya | $21 |
| LEO Pharma | Meals · 2025-12-19 | Adbry | $15 |
| LEO Pharma | Meals · 2025-12-19 | Adbry | $15 |
| Abbvie | Meals · 2025-12-18 | Skyrizi | $9 |
| Sun Pharmaceutical Industries | Meals · 2025-12-18 | Ilumya | $32 |
| Incyte | Meals · 2025-12-17 | Opzelura | $28 |
| Galderma Laboratories L.P. | Meals · 2025-12-15 | Nemluvio | $37 |
| Ucb | Meals · 2025-12-12 | Bimzelx | $37 |
| LEO Pharma | Meals · 2025-12-11 | Adbry | $15 |
| LEO Pharma | Meals · 2025-12-11 | Adbry | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-12-10 | Dupixent | $27 |
| Janssen Biotech | Meals · 2025-12-06 | Tremfya | $20 |
| Novartis Pharmaceuticals | Meals · 2025-12-04 | Rhapsido | $24 |
| Organon | Meals · 2025-12-03 | Vtama | $32 |
| Arcutis Biotherapeutics | Meals · 2025-12-02 | Zoryve | $20 |
| Novartis Pharmaceuticals | Meals · 2025-12-01 | Rhapsido | $26 |
| Amgen | Meals · 2025-11-25 | Otezla | $34 |
| Incyte | Meals · 2025-11-20 | Opzelura | $28 |
| Arcutis Biotherapeutics | Meals · 2025-11-20 | Zoryve | $8 |
| Sun Pharmaceutical Industries | Meals · 2025-11-13 | Winlevi | $33 |
| Arcutis Biotherapeutics | Meals · 2025-11-13 | Zoryve | $181 |
| Cipher Pharmaceuticals US | Meals · 2025-11-11 | Natroba | $15 |
| LEO Pharma | Meals · 2025-11-07 | Adbry | $26 |
| Incyte | Meals · 2025-11-06 | Opzelura | $24 |
| Genzyme | Meals · 2025-11-05 | Dupixent | $37 |
| LEO Pharma | Meals · 2025-10-24 | Adbry | $21 |
| Abbvie | Meals · 2025-10-23 | Skyrizi | $9 |
| Genzyme | Meals · 2025-10-23 | Dupixent | $34 |
| Galderma Laboratories L.P. | Meals · 2025-10-22 | Nemluvio | $33 |
| Regeneron Healthcare Solutions | Meals · 2025-10-16 | Dupixent | $27 |
| Galderma Laboratories L.P. | Meals · 2025-10-16 | Nemluvio | $15 |
| Galderma Laboratories L.P. | Meals · 2025-10-16 | Nemluvio | $7 |
| Lilly USA | Meals · 2025-10-15 | Taltz | $33 |
| Arcutis Biotherapeutics | Meals · 2025-10-15 | Zoryve | $13 |
| Novartis Pharmaceuticals | Meals · 2025-10-13 | Rhapsido | $19 |
| Incyte | Meals · 2025-10-08 | Opzelura | $24 |
| LEO Pharma | Meals · 2025-10-08 | Adbry | $5 |
| LEO Pharma | Meals · 2025-10-08 | Adbry | $8 |
| Galderma Laboratories L.P. | Meals · 2025-10-06 | Nemluvio | $29 |
| Arcutis Biotherapeutics | Meals · 2025-10-01 | Zoryve | $25 |
| Abbvie | Meals · 2025-09-24 | Rinvoq | $24 |
| Lilly USA | Meals · 2025-09-23 | Taltz | $28 |
| Incyte | Meals · 2025-09-17 | Opzelura | $29 |
| Arcutis Biotherapeutics | Meals · 2025-09-15 | Zoryve | $13 |
| LEO Pharma | Meals · 2025-09-11 | Adbry | $21 |
| Lilly USA | Meals · 2025-09-10 | Ebglyss | $26 |
| Janssen Biotech | Meals · 2025-09-04 | Tremfya | $22 |
| Janssen Biotech | Meals · 2025-09-04 | Tremfya | $4 |
| Janssen Biotech | Meals · 2025-09-04 | Tremfya | $0 |
| Lilly USA | Meals · 2025-09-04 | Taltz | $20 |
| Lilly USA | Meals · 2025-09-04 | Taltz | $1 |
| Incyte | Meals · 2025-09-04 | Opzelura | $26 |
| Galderma Laboratories L.P. | Meals · 2025-08-28 | Nemluvio | $38 |
| Arcutis Biotherapeutics | Meals · 2025-08-28 | Zoryve | $6 |
| Lilly USA | Meals · 2025-08-27 | Taltz | $11 |
| Lilly USA | Meals · 2025-08-27 | Taltz | $11 |
| Genzyme | Meals · 2025-08-27 | Dupixent | $33 |
| Abbvie | Meals · 2025-08-21 | Skyrizi | $28 |
| Lilly USA | Meals · 2025-08-20 | Taltz | $24 |
| Arcutis Biotherapeutics | Meals · 2025-08-18 | Zoryve | $5 |
| Janssen Biotech | Education · 2025-08-14 | Tremfya | $95 |
| Janssen Biotech | Meals · 2025-08-13 | Tremfya | $32 |
| Lilly USA | Meals · 2025-08-07 | Taltz | $29 |
| Incyte | Meals · 2025-08-06 | Opzelura | $30 |
| Lilly USA | Meals · 2025-07-29 | Taltz | $29 |
| Janssen Biotech | Meals · 2025-07-24 | Tremfya | $2 |
| Janssen Biotech | Meals · 2025-07-23 | Tremfya | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-07-23 | Dupixent | $26 |
| Abbvie | Meals · 2025-07-22 | Skyrizi | $5 |
| Abbvie | Meals · 2025-07-19 | Skyrizi | $17 |
| Amgen | Meals · 2025-07-14 | Otezla | $31 |
| Pfizer | Meals · 2025-07-14 | Cibinqo | $15 |
| Arcutis Biotherapeutics | Meals · 2025-07-14 | Zoryve | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-07-11 | Dupixent | $20 |
| Arcutis Biotherapeutics | Meals · 2025-07-03 | Zoryve | $18 |
| Arcutis Biotherapeutics | Meals · 2025-06-30 | Zoryve | $13 |
| Incyte | Meals · 2025-06-27 | Opzelura | $2 |
| Incyte | Meals · 2025-06-26 | Opzelura | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-06-24 | Dupixent | $27 |
| Lilly USA | Meals · 2025-06-18 | Taltz | $29 |
| Arcutis Biotherapeutics | Meals · 2025-06-18 | Zoryve | $9 |
| Janssen Biotech | Meals · 2025-06-12 | Tremfya | $32 |
| Arcutis Biotherapeutics | Meals · 2025-06-12 | Zoryve | $10 |
| Arcutis Biotherapeutics | Meals · 2025-06-12 | Zoryve | $6 |
| Lilly USA | Meals · 2025-06-11 | Taltz | $30 |
| Abbvie | Meals · 2025-05-21 | Rinvoq | $12 |
| Abbvie | Meals · 2025-05-21 | Rinvoq | $17 |
| Incyte | Meals · 2025-05-21 | Opzelura | $17 |
| Lilly USA | Meals · 2025-05-20 | Taltz | $4 |
| Lilly USA | Meals · 2025-05-18 | Taltz | $28 |
| Arcutis Biotherapeutics | Meals · 2025-05-18 | Zoryve | $14 |
| Ucb | Meals · 2025-05-14 | Bimzelx | $33 |
| Arcutis Biotherapeutics | Meals · 2025-05-05 | Zoryve | $33 |
| Lilly USA | Meals · 2025-04-30 | Taltz | $25 |
| Arcutis Biotherapeutics | Meals · 2025-04-28 | Zoryve | $21 |
| Incyte | Meals · 2025-04-22 | Opzelura | $28 |
| Abbvie | Meals · 2025-04-21 | Skyrizi | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-17 | Sotyktu | $15 |
| Incyte | Meals · 2025-04-10 | Opzelura | $15 |
| Lilly USA | Meals · 2025-04-09 | Taltz | $30 |
| Pfizer | Meals · 2025-04-08 | Cibinqo | $29 |
| Arcutis Biotherapeutics | Meals · 2025-03-27 | Zoryve | $25 |
| Galderma Laboratories L.P. | Meals · 2025-03-21 | Nemluvio | $31 |
| Janssen Biotech | Meals · 2025-03-19 | Tremfya | $26 |
| Arcutis Biotherapeutics | Meals · 2025-03-17 | Zoryve | $2 |
| Organon | Meals · 2025-03-05 | Vtama | $31 |
| Ucb | Meals · 2025-02-28 | Bimzelx | $22 |
| Arcutis Biotherapeutics | Meals · 2025-02-26 | Zoryve | $23 |
| Galderma Laboratories L.P. | Meals · 2025-02-19 | Nemluvio | $43 |
| Incyte | Meals · 2025-02-13 | Opzelura | $30 |
| Arcutis Biotherapeutics | Meals · 2025-02-10 | Zoryve | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-02-06 | Dupixent | $24 |
| Arcutis Biotherapeutics | Meals · 2025-01-30 | Zoryve | $29 |
| Janssen Biotech | Meals · 2025-01-23 | Tremfya | $29 |
| Amgen | Meals · 2025-01-21 | Otezla | $33 |
| Abbvie | Meals · 2025-01-13 | Skyrizi | $27 |
| Arcutis Biotherapeutics | Meals · 2025-01-13 | Zoryve | $12 |
| Janssen Biotech | Meals · 2025-01-11 | Tremfya | $1 |
| Janssen Biotech | Meals · 2025-01-11 | Tremfya | $16 |
| Regeneron Healthcare Solutions | Meals · 2025-01-08 | Dupixent | $25 |
| Organon | Meals · 2025-01-07 | Vtama | $10 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,336
| Arcutis Biotherapeutics | Zoryve | $286 | 15 payments
|
| Regeneron Healthcare Solutions | Dupixent | $231 | 8 payments
|
| Janssen Biotech | Tremfya | $212 | 10 payments
|
| Amgen | Otezla | $194 | 6 payments
|
| Sun Pharmaceutical Industries | Ilumya | $111 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $87 | 3 payments
|
| Dermavant Sciences | Vtama | $56 | 2 payments
|
| Pfizer | Cibinqo | $41 | 2 payments
|
| Abbvie | Skyrizi | $35 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $32 | 1 payment
|
| Incyte | Opzelura | $30 | 2 payments
|
| Galderma Laboratories L.P. | None | $21 | 1 payment
|
2023: $987
| Abbvie | Skyrizi | $244 | 11 payments
|
| Regeneron Healthcare Solutions | Dupixent | $228 | 7 payments
|
| LEO Pharma | Adbry | $108 | 4 payments
|
| Janssen Biotech | Tremfya | $85 | 3 payments
|
| Pfizer | Eucrisa | $74 | 4 payments
|
| Dermavant Sciences | Vtama | $60 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $56 | 2 payments
|
| Incyte | Opzelura | $39 | 2 payments
|
| Amgen | Amjevita | $33 | 1 payment
|
| Genzyme | Fabrazyme | $31 | 1 payment
|
| Arcutis Biotherapeutics | None | $30 | 1 payment
|
2022: $352
| Regeneron Healthcare Solutions | Dupixent | $101 | 4 payments
|
| LEO Pharma | Adbry | $93 | 4 payments
|
| Incyte | Opzelura | $49 | 2 payments
|
| Abbvie | Rinvoq | $47 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $24 | 1 payment
|
| Genzyme | Fabrazyme | $21 | 1 payment
|
| Lilly USA | Taltz | $17 | 1 payment
|
2021: $99
| AbbVie | Skyrizi | $72 | 4 payments
|
| Janssen Biotech | Tremfya | $27 | 1 payment
|
2020: $69
| AbbVie | Skyrizi | $69 | 3 payments
|
2019: $15
| AbbVie | Humira | $15 | 1 payment
|
Professional record
- NPI
- 1932527686
- Licence
- CA A137652California A137652: Current · expires 2027-05-31
- Trained
- Harvard Medical School, 2014
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2014-03-31
- NPI last updated
- 2020-06-19
- NPI record certified
- 2020-06-19
This is when the NPI record was last certified, not a medical board exam.